Novartis AG Sponsored ADR (0K9E)
LSE
Real-time Data
07:00 AM
Day's Range
156.0552 wk Range
118.06Overview - 0K9E - Novartis AG Sponsored ADR
Key Statistics
Valuation
Enterprise Value
344.05B
P/E (Trailing)
‪0.14‬
Price / Book
‪7.27‬
EV / EBITDA
‪14.89‬
Profitability
Profit Margin
‪22.50%‬
Operating Margin
‪34.62%‬
Return on Assets
‪10.25%‬
Return on Equity
‪30.35%‬
Ownership
Shares Outstanding
2.30B
Float
1.85B
Held by Insiders
‪0.01%‬
Held by Institutions
‪7.26%‬
Price stats
Beta
‪0.49‬
50-Day Avg
‪103.84‬
200-Day Avg
‪100.29‬
Dividends
Frequency
Annual
Market Cap - 0K9E - Novartis AG Sponsored ADR
Peers - 0K9E - Novartis AG Sponsored ADR
Peer Comparison
Compared with companies in Drug Manufacturers - General listed on LSE.
- 0K9ELSENovartis AG Sponsored ADR367.33BMarket Cap+20.90%52-week change0.15P/E (Trailing)‪22.50%‬Profit Margin
- AZNLSEAstraZeneca PLC22.41TMarket Cap+29.32%52-week change28.74P/E (Trailing)‪17.18%‬Profit Margin
- GSKLSEGSK plc7.68TMarket Cap+23.02%52-week change16.26P/E (Trailing)‪14.52%‬Profit Margin
- 0QIULSENovo Nordisk A/S1.24TMarket Cap-23.24%52-week change19.95P/E (Trailing)‪33.39%‬Profit Margin
- 0Q1GLSEEli Lilly and Company686.33BMarket Cap+54.90%52-week change1.56P/E (Trailing)‪33.52%‬Profit Margin
- 0QCVLSEAbbVie Inc.478.52BMarket Cap+21.83%52-week change54.73P/E (Trailing)‪15.50%‬Profit Margin
- 0QAHLSEMerck & Co., Inc.383.85BMarket Cap+44.02%52-week change63.23P/E (Trailing)‪5.33%‬Profit Margin
Profile Summary - 0K9E - Novartis AG Sponsored ADR
About
Novartis AG Sponsored ADR represents ownership in Novartis AG, a global healthcare company focused on researching, developing, manufacturing, and marketing innovative medicines. Through this ADR structure, U.S. investors can gain exposure to Novartis AG shares in U.S. dollars, with each depositary receipt backed by an…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
